Literature DB >> 34245227

Bayesian meta-analysis using SAS PROC BGLIMM.

Kollin W Rott1, Lifeng Lin2, James S Hodges1, Lianne Siegel1, Amy Shi3, Yong Chen4, Haitao Chu1.   

Abstract

Meta-analysis is commonly used to compare two treatments. Network meta-analysis (NMA) is a powerful extension for comparing and contrasting multiple treatments simultaneously in a systematic review of multiple clinical trials. Although the practical utility of meta-analysis is apparent, it is not always straightforward to implement, especially for those interested in a Bayesian approach. This paper demonstrates that the recently-developed SAS procedure BGLIMM provides an intuitive and computationally efficient means for conducting Bayesian meta-analysis in SAS, using a worked example of a smoking cessation NMA data set. BGLIMM gives practitioners an effective and simple way to implement Bayesian meta-analysis (pairwise and network, either contrast-based or arm-based) without requiring significant background in coding or statistical modeling. Those familiar with generalized linear mixed models, and especially the SAS procedure GLIMMIX, will find this tutorial a useful introduction to Bayesian meta-analysis in SAS.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  BGLIMM; Bayesian methods; SAS; multiple treatment comparisons; network meta-analysis

Mesh:

Year:  2021        PMID: 34245227      PMCID: PMC8867920          DOI: 10.1002/jrsm.1513

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  26 in total

1.  Network meta-analysis for indirect treatment comparisons.

Authors:  Thomas Lumley
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

2.  Statistical approaches for conducting network meta-analysis in drug development.

Authors:  Byron Jones; James Roger; Peter W Lane; Andy Lawton; Chrissie Fletcher; Joseph C Cappelleri; Helen Tate; Patrick Moneuse
Journal:  Pharm Stat       Date:  2011 Nov-Dec       Impact factor: 1.894

3.  Modeling between-trial variance structure in mixed treatment comparisons.

Authors:  Guobing Lu; Ae Ades
Journal:  Biostatistics       Date:  2009-08-17       Impact factor: 5.899

4.  Meta-analysis of multitreatment studies.

Authors:  V Hasselblad
Journal:  Med Decis Making       Date:  1998 Jan-Mar       Impact factor: 2.583

5.  The impact of covariance priors on arm-based Bayesian network meta-analyses with binary outcomes.

Authors:  Zhenxun Wang; Lifeng Lin; James S Hodges; Haitao Chu
Journal:  Stat Med       Date:  2020-06-03       Impact factor: 2.373

6.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

7.  Rejoinder to the discussion of "a Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons," by S. Dias and A. E. Ades.

Authors:  Hwanhee Hong; Haitao Chu; Jing Zhang; Bradley P Carlin
Journal:  Res Synth Methods       Date:  2015-10-13       Impact factor: 5.273

8.  Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: methods for the absolute risk difference and relative risk.

Authors:  Haitao Chu; Lei Nie; Yong Chen; Yi Huang; Wei Sun
Journal:  Stat Methods Med Res       Date:  2010-12-21       Impact factor: 3.021

Review 9.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Authors:  Deborah M Caldwell; A E Ades; J P T Higgins
Journal:  BMJ       Date:  2005-10-15

10.  Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.

Authors:  Sofia Dias; Alex J Sutton; A E Ades; Nicky J Welton
Journal:  Med Decis Making       Date:  2012-10-26       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.